Sun YoungOhMD

Oncology • Bronx, NY

Physician

Join to view full profile

Dr. Oh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Oh's full profile

Already have an account?

Office
1695 eastchester road
Bronx, NY 10461
Phone+1 718-405-8404

Fax+1 718-405-8433

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2005 - 2006
Ewha Women's University College of MedicineClass of 2003

Certifications & Licensure

NY State Medical License 2015 - 2025
MA State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer Start of enrollment: 2018 Jun 21
Active, not recruiting
Phase 2
Roles: Contact
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer Start of enrollment: 2022 Mar 07
Recruiting
Phase 3
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast Cancer.
Jesus D Anampa, Daniel L Flynn, Cynthia Leary, Sun Oh, Xiaonan Xue
Clinical Cancer Research. 2025-01-17
Trends in Incidence of Invasive Lobular Carcinoma of the Breast by Race: Patterns by Age, Cancer Stage, and Socioeconomic Factors in the United States, 1992-2019.
Ryann M Quinn, Ana M Bernal, Sun Young Oh, Jesus D Anampa
Clinical Breast Cancer. 2024-12-30
Neoadjuvant T-DM1 for HER2-positive breast cancer used as a bridging strategy during COVID-19 pandemic: lessons learned-a case series.
Adrian Choppa, Fardeen Bhimani, Angela Foley, Sun Young Oh, Della Makower
Gland Surgery. 2024-06-30